Neutral
Biohaven (BHVN) Stock Looks Rich After Pivotal Trial Plans Lift Shares
Biohaven's stock rose 12.66% after announcing plans for pivotal clinical studies for cancer and autoimmune candidates. Despite recent short-term gains...